Z-1409-2021 Class III Terminated

Recalled by OriGen Biomedical, Inc. — Austin, TX

FDA device recall Z-1409-2021 was initiated by OriGen Biomedical, Inc. on Jan 28, 2021 and is designated Class III. Reason for recall: It was identified that tissue culture bags were incorrectly labeled as free of phthalates. The recall status is terminated (terminated Apr 19, 2023). Affected quantity: 1201 units.

Recall details

Product Type
Devices
Report Date
Apr 21, 2021
Initiation Date
Jan 28, 2021
Termination Date
Apr 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1201 units

Product description

Evolve Cell Culture Bags, part numbers: EV1000N and EV3000N The Evolve bag is made of Ethyl Vinyl Olefin (EVO) and contains no BPA or latex. The bag can be supplied with tubing sets that can include, but are not limited to, the following components: EVA/PVC coextruded tubing, PVC tubing, Yconnectors, needle-free valves, female luers, male luers and/or caps

Reason for recall

It was identified that tissue culture bags were incorrectly labeled as free of phthalates.

Distribution pattern

US: TX, LA, IA, NC, OH, NY, MA, MD, IL, PA, CA, KS, TN, RI, OR, FL, NJ, CT, Puerto Rico OUS: None

Code information

All Lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1409-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1409-2021. Report a data issue: hello@regdatalab.com.